|

Proton Therapy for Mediastinal Lymphoma (PROMLY)

RECRUITINGN/ASponsored by Rigshospitalet, Denmark
Actively Recruiting
PhaseN/A
SponsorRigshospitalet, Denmark
Started2026-05-01
Est. completion2046-05-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07817641

Summary

The study aims to investigate whether proton therapy is feasible in a national setting and whether proton therapy can reduce the risk of late toxicity (secondary cancers and heart toxicity) compared to foton therapy.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients 18 years or older
* Histologically proven Hodgkin or non-Hodgkin lymphoma
* Disease constrained within the mediastinum +/- neck and/or axilla involvement.
* Candidates for curative intended treatment
* Signed written informed consent.

Exclusion Criteria:

* Prior radiotherapy to the thorax
* Other current malignancy
* Inability to attend full course of radiotherapy or follow-up visits in the outpatient clinic.

Conditions4

CancerDiffuse Large B-cell Lymphoma(DLBCL)Hodgkin Disease LymphomaMediastinal Lymphoma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.